Skip to main content

Table 1 Baseline characteristics of study participants

From: Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial

Characteristics

AS + DP N = 79

AS + AL N = 71

Female (%)

36 (45.6)

36 (50.7)

Age in months*

17 (11–26)

16 (10–26)

Weight (kg)*

9.5 (8–11.5)

9 (8.1–11)

Temperature (°C)*

38.8 (37.7–39.5)

39.1 (37.7–39.5)

Parasite density per μL, log10 copies*

4.82 (4.29–5.10)

4.79 (4.38–5.02)

Haemoglobin (mg/dL)*

9.1 (7.9–10.5)

9.2 (8.4–10.6)

Total white blood cell count (*103/μL)*

9.6 (6.9–13.2)

9.2 (7.5–12.3)

Random blood sugar (mmol/L)*

7.3 (6.3–8.3)

6.8 (6.4–8.3)

Complications at admission, n (%)

 Patients with history of repeated convulsions n (%)

6 (7.6%)

3 (4.2%)

 Patients with history of inability to feed

26 (33.0%)

24 (34.0%)

 Patients with prostration (extreme weakness)

22 (27.9%)

15 (21.13%)

 Haemoglobinuria

0

0

 Jaundice

2 (2.5%)

0

 Severe anaemia

0

0

 Respiratory distress

2 (2.5%)

6 (8.5%)

 Impaired consciousness

0

0

 Abnormal bleeding

2 (2.5%)

1 (1.4%)

 Hypoglycaemia

0

0

  1. * Values are presented as medians (IQR)